Medical Weight Loss Update
We want to share an important update regarding tirzepatide, a key part of our weight loss program at Icon Aesthetics.
Compounded Tirzepatide Availability
​
Tirzepatide has been removed from the FDA shortage list, and compounding pharmacies can continue to produce it until March 19, 2025. After this date, tirzepatide will no longer be available from compounding pharmacies.
To help ensure access, we can secure a supply that will last up to six months in our clinic. Each vial, whether obtained via mail, or purchased from our clinic, will remain effective for 60 days from the first puncture.
We are currently offering the following vial sizes:
• 18 mg: $300
• 36 mg: $550
• 54 mg: $800
• 72 mg: $1,050
Next Steps
If you would like to receive tirzepatide beyond March 2025, please text “interested” to (304)488-8446 as soon as possible so we can plan accordingly.
Alternative Plans
Should tirzepatide become unavailable, we are prepared to help you transition to semaglutide, another highly effective GLP-1 medication for weight loss. Icon Aesthetics can also prescribe the brand-name, non-compounded versions, Zepbound and Mounjaro, which often results in a higher, out-of-pocket cost for patients.
Flexible Payment Options
We are pleased to offer payment plans through Cherry to make your care more accessible. To learn more or apply, visit pay.withcherry.com/icon-wv?utm_source=merchant&utm_medium=website.
We are committed to supporting your health journey through these changes. If you have questions or would like to discuss your options, please contact us or reply to this email.
Thank you for trusting us with your care!
Warm regards,
Hiatt Wolfe, PA
Matthew Yoak, MD
​
Icon Aesthetics & Lifestyle Medicine
325 Ninth St.
Parkersburg, WV 26101
(304)488-8446
​